Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Celcuity Inc.CELC · Entity 3991 | Director | May 16, 2019 | May 20, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Celcuity Inc.
Report date May 16, 2019 · Filed May 20, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $22.45 · Expires 2029-05-16 | Direct | 5,054 |
Reported balance
After 2019-05-16 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-05-16 · Grant · Acquired 5,054 · Balance 5,054 F1: This Option will vest and become exercisable on April 30, 2020, or if earlier, the date of the Company's 2020 Annual Meeting of Stockholders. |
| Common StockSEC Table I · non-derivative | Direct | 7,821 |
Reported balance
Holding disclosure · report date 2019-05-16 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 7,821 |
Filing footnotes · ownership attribution and instrument terms
F1: This Option will vest and become exercisable on April 30, 2020, or if earlier, the date of the Company's 2020 Annual Meeting of Stockholders.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 16, 2019 Filed May 20, 2019 20:04 UTC | Celcuity Inc. CELC · Entity 3991 | GrantStock Option (right to buy) · Derivative | 5,054 | $0.00 Strike: $22.45 | $0.00 |
DisclosureSEC source: 0000914190-19-000177 · edgar.xml · derivative · entry 2 Cronin Maureen Therese · CIK 0001716105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,054 Underlying: Common Stock · 5,054 shares Expires 2029-05-16 F1 · derivative.exercise_date: This Option will vest and become exercisable on April 30, 2020, or if earlier, the date of the Company's 2020 Annual Meeting of Stockholders. Read SEC document |
| May 14, 2018 Filed May 16, 2018 20:48 UTC | Celcuity Inc. CELC · Entity 3991 | GrantCommon Stock | 2,571 | $0.00 | $0.00 |
DisclosureSEC source: 0000914190-18-000205 · edgar.xml · nonDerivative · entry 1 Cronin Maureen Therese · CIK 0001716105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,821 F1 · shares: The Shares will vest, and the risk of forfeiture will lapse, on April 30, 2019 or, if earlier, the date of the Company's 2019 Annual Meeting of Stockholders. Read SEC document |
| October 26, 2017 Filed Oct 26, 2017 20:32 UTC | Celcuity Inc. CELC · Entity 3991 | GrantCommon Stock | 5,250 | $0.00 | $0.00 |
DisclosureSEC source: 0000914190-17-000339 · edgar.xml · nonDerivative · entry 1 Cronin Maureen Therese · CIK 0001716105 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,250 F1 · shares: Represents 5,250 shares of restricted stock for which the risk of forfeiture lapses on 4/30/18. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.